Multimodal Training Effects in Middle-Aged and Older Adults With Diabetic Sarcopenia
- Sponsor
- yueh chu wu
- Study ID
- NCT07398495
- Status
- Recruiting
Conditions
- Sarcopenia
- Type 2 Diabetes Mellitus (T2DM)
Eligibility Criteria
- Sex
- ALL
- Age
- 45 Years - 85 Years
- Healthy Volunteers
- Not accepted
Interventions
- Multimodal Exercise Program — BEHAVIORALParticipants will engage in a 12-week multimodal exercise program comprising supervised training sessions, home-based exercises, and digital support. To facilitate adherence and proper technique, participants will also receive a "Diabetes and Muscle Health Handbook" as a training guide.
Study Details
This study aims to investigate the effects of a 12-week multimodal exercise intervention on middle-aged and older adults (aged 45\~85 years) with Type 2 Diabetes Mellitus (T2DM). The program combines supervised training, home-based sessions, and digital support to improve muscle function, physical performance, metabolic control, and quality of life.
Key Dates
- First listed
- Feb 10, 2026
- Start date
- Feb 23, 2026
- Status verified
- Mar 2026
- Primary completion
- May 15, 2026
- Completion
- Aug 15, 2026
Study Design
- Enrollment
- 128 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Intervention Group (Multimodal Exercise)• Arm Description: Participants in this group will engage in a 12-week multimodal exercise program. The program includes supervised training sessions, home-based exercises, and digital support. They will also receive a "Diabetes and Muscle Health Handbook" to guide their training.
- No Intervention: Control Group (Standard Care)Participants in this group will serve as the control. They will receive a "Nutrition and Muscle Health Education Sheet" at the beginning of the study. They will not participate in the multimodal exercise program and will continue with their routine health management based on existing medical advice.
Primary Outcome Measure
Physical Function (5TSTS) [ Time Frame: Change from Baseline at Week 12 and Week 24 ]
Central Contacts
- yueh chu wu WU YUEH CHU886-952680613
Related Studies
- Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal CancerRecruiting · Wake Forest University Health Sciences · Millville, Delaware
- Low-Dose Pioglitazone in Patients With NASH (AIM 2)PHASE2 · Recruiting · University of Florida · Gainesville, Florida
- Identifying Modifiable PAtient Centered Therapeutics (IMPACT) FrailtyRecruiting · University of California, Los Angeles · Los Angeles, California
- Sarcopenia Magnetic Resonance Imaging Evaluation (SUSIE)Enrolling By Invitation · The Cleveland Clinic · Cleveland, Ohio